Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Senti Biosciences, Inc. (SNTI) had Normalized Pre-Tax Income of $-14.73M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-14.73M |
|
-- |
|
-- |
|
$16.80M |
|
$-16.80M |
|
$2.06M |
|
$-14.73M |
|
|
Normalized Pre-Tax Income |
$-14.73M |
$-14.73M |
|
$-14.73M |
|
$-14.73M |
|
$-14.73M |
|
$-16.80M |
|
$-16.43M |
|
26.08M |
|
26.08M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$32.52M |
|
$19.59M |
|
$36.02M |
|
$68.54M |
|
$9.99M |
|
-- |
|
$33.90M |
|
$43.89M |
|
$24.65M |
|
$24.65M |
|
$24.65M |
|
26.16M |
|
| Cash Flow Statement Financials | |
$-27.12M |
|
$-0.18M |
|
$0.60M |
|
$51.81M |
|
$25.11M |
|
$-26.71M |
|
$2.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.76% |
|
-59.76% |
|
-21.50% |
|
-59.76% |
|
$0.94 |
|
$-1.05 |
|
$-1.04 |
|